Hypercholesterolemia and Dyslipidemia: Issues for the Clinician

Area of Science:

• Lipidology and Cardiovascular Diagnostics
• Personalized Medicine in Cardiology

Background:

• The standard lipid profile (LDL, HDL, triglycerides) is insufficient for comprehensive coronary artery disease risk assessment.
• Lipoprotein disorders contribute significantly to cardiovascular disease, necessitating more advanced diagnostic approaches.

Purpose of the Study:

• To highlight the clinical utility of advanced lipoprotein testing beyond the basic lipid profile.
• To emphasize the importance of personalized treatment strategies tailored to specific lipoprotein disorders.

Main Methods:

• Incorporation of atherogenic lipoprotein profile (ALP), lipoprotein subclass distribution (LDL and HDL), apolipoprotein E isoforms, lipoprotein (a), homocysteine, and high-sensitivity C-reactive protein.
• Utilization of sophisticated laboratory tests available through technology transfer programs.

Main Results:

• Advanced testing provides a more detailed and accurate diagnosis of disorders contributing to coronary artery disease.
• Specific diagnostic findings guide tailored treatment, leading to greater clinical benefit in patient subgroups.

Conclusions:

• Clinicians can achieve more personalized diagnoses and treatments for cardiovascular disease risk by integrating advanced lipoprotein analyses.
• Treatment must be individualized to specific lipoprotein disorders for optimal therapeutic efficacy, moving beyond one-size-fits-all approaches.